Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decreased SIRT1 Activity Is Involved in the Acute Injury Response of Chondrocytes to Ex Vivo Injurious Mechanical Overload. | Int J Mol Sci | 2023 | 37047494 | PubTator, text mining | PubMed |
| Oestrogen and Vibration Improve Intervertebral Disc Cell Viability and Decrease Catabolism in Bovine Organ Cultures. | Int J Mol Sci | 2023 | 37047116 | PubTator, text mining | PubMed |
| Sex-dependent variation in cartilage adaptation: from degeneration to regeneration. | Biol Sex Differ | 2023 | 37024929 | PubTator, text mining | PubMed |
| Role of the PADI family in inflammatory autoimmune diseases and cancers: A systematic review. | Front Immunol | 2023 | 37020554 | PubTator, text mining | PubMed |
| Expression of ADAMTS 1-4-8 and placental growth factor in ovary and oviduct during pregnancy in the first trimester. | Anat Histol Embryol | 2023 | 37014320 | PubTator, text mining | PubMed |
| Regulation and therapy, the role of JAK2/STAT3 signaling pathway in OA: a systematic review. | Cell Commun Signal | 2023 | 37013568 | PubTator, text mining | PubMed |
| Lutein attenuates Propionibacterium acnes-induced inflammation by inhibiting pyroptosis of human keratinocyte cells via TLR4/NLRP3/Caspase-1 pathway. | Int Immunopharmacol | 2023 | 37012890 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived secretome enhances nucleus pulposus cell metabolism and modulates extracellular matrix gene expression in vitro. | Front Bioeng Biotechnol | 2023 | 37008028 | PubTator, text mining | PubMed |
| The protective activity of natural flavonoids against osteoarthritis by targeting NF-κB signaling pathway. | Front Endocrinol (Lausanne) | 2023 | 36998478 | PubTator, text mining | PubMed |
| Smart Hydrogels for Bone Reconstruction via Modulating the Microenvironment. | Research (Wash D C) | 2023 | 36996343 | PubTator, text mining | PubMed |
| Intervertebral disc degeneration and how it leads to low back pain. | JOR Spine | 2023 | 36994466 | PubTator, text mining | PubMed |
An update on animal models of intervertebral disc degeneration and low back pain: Exploring the potential of artificial intelligence to improve research analysis and development of prospective therapeutics. | JOR Spine | 2023 | 36994457 | PubTator, text mining | PubMed |
| Harmonization and standardization of nucleus pulposus cell extraction and culture methods. | JOR Spine | 2023 | 36994456 | PubTator, text mining | PubMed |
| Antioxidative behavior of a2-macroglobulin in intervertebral disc degeneration. | J Med Biochem | 2023 | 36987418 | PubTator, text mining | PubMed |
| Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues. | Pharmaceuticals (Basel) | 2023 | 36986536 | PubTator, text mining | PubMed |
| The Role of Tocotrienol in Arthritis Management-A Scoping Review of Literature. | Pharmaceuticals (Basel) | 2023 | 36986484 | PubTator, text mining | PubMed |
| Biomarkers of Osteoarthritis-A Narrative Review on Causal Links with Metabolic Syndrome. | Life (Basel) | 2023 | 36983885 | PubTator, text mining | PubMed |
| Safety of Epidural Hyaluronic Acid Injections in Managing the Symptoms of Lumbar Foraminal Stenosis: A Prospective Preliminary Study. | J Clin Med | 2023 | 36983359 | PubTator, text mining | PubMed |
| New Insights into the Role of Synovial Fibroblasts Leading to Joint Destruction in Rheumatoid Arthritis. | Int J Mol Sci | 2023 | 36982247 | PubTator, text mining | PubMed |
| The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment-A Systematic Review. | Cancers (Basel) | 2023 | 36980765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=14